← Benitec Biopharma Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $15.7m $9.8m $19.8m $4.1m $2.5m $50.9m $97.7m
Prepaid Expense and Other Assets, Current — — $814k $741k $1.2m $516k $628k
Trade and other receivables $2.5m $59k $25k $3k $55k $229k $33k
Prepaid and other assets — $949k $814k $741k $97k $62k $28k
Accounts Receivable — — — $3k $55k $229k $33k
Cash Cash Equivalents And Short Term Investments — — — $4.1m $2.5m $50.9m $97.7m
Non Current Prepaid Assets — — — $25k $25k $87k $83k
Other Current Assets — — — $741k $1.2m $516k $628k
Assets, Current — $10.8m $20.6m $4.8m $3.7m $51.7m $98.5m
Total current assets $18.8m $10.8m $20.6m $4.8m $3.7m $51.7m $98.5m
Property, Plant and Equipment, Net $470k $374k $375k $222k $87k $179k $131k
Operating Lease, Right-of-Use Asset — $395k $202k $771k $526k $270k $860k
Other Assets, Noncurrent — — $185k $135k $97k $62k $28k
Right-of-use assets $579k $395k $202k $771k $526k $270k $860k
Restricted cash — — $15k $14k $13k $63k $113k
Deposits $9k $9k $9k $25k $25k $25k $55k
Trade and other payables $2.5m $741k $880k $1.9m $3.2m $4.2m $1.0m
Lease liabilities, current portion — $192k $213k $252k $275k $284k $354k
Lease liabilities, less current portion — $213k — $559k $284k $0 $495k
Accumulated Depreciation — — — ($1.2m) ($1.3m) ($1.4m) ($1.5m)
Buildings And Improvements — — — $771k $526k $270k $860k
Capital Lease Obligations — — — $811k $559k $284k $849k
Cash Financial — — — $4.1m $2.5m $50.9m $97.7m
Current Accrued Expenses — — — $1.4m $2.0m $2.7m $754k
Current Capital Lease Obligation — — — $252k $275k $284k $354k
Current Debt And Capital Lease Obligation — — — $252k $275k $284k $354k
Employee Benefits — — — — — $38k $0
Gross PPE — — — $2.2m $1.9m $1.9m $2.5m
Invested Capital — — — $2.9m $202k $47.2m $97.3m
Leases — — — $24k $24k $24k $24k
Long Term Capital Lease Obligation — — — $559k $284k $0 $495k
Machinery Furniture Equipment — — — $37k $38k $38k $44k
Net PPE — — — $993k $613k $449k $991k
Net Tangible Assets — — — $2.9m $202k $47.2m $97.3m
Ordinary Shares Number — — — $481k $1.6m $10.1m $26.3m
Other Equity Adjustments — — — ($1.2m) ($830k) ($892k) ($839k)
Other Non Current Assets — — — $135k $97k $62k —
Other Payable — — — $71k $69k $138k $67k
Other Properties — — — $1.3m $1.3m $1.5m $1.5m
Properties — — — $0 $0 $0 $0
Share Issued — — — $481k $1.6m $10.1m $26.3m
Tangible Book Value — — — $2.9m $202k $47.2m $97.3m
Working Capital — — — $2.3m ($249k) $46.8m $96.7m
Total Capitalization — — — $2.9m $202k $47.2m $97.3m
Total Debt — — — $811k $559k $284k $849k
Total Non Current Assets — — — $1.2m $735k $536k $1.1m
Assets $19.2m $11.6m $21.4m $6.0m $4.5m $52.2m $99.6m
LIABILITIES AND EQUITY
Total liabilities and stockholders' equity $19.2m $11.6m $21.4m $6.0m $4.5m $52.2m $99.6m
Current liabilities:
Operating Lease, Liability, Current — $192k $213k $252k $275k $284k $354k
Operating Lease, Liability, Noncurrent — $213k — $559k $284k $0 $495k
Accrued employee benefits $147k $203k $276k $400k $472k $475k $426k
Accounts Payable — — — $422k $1.1m $1.4m $201k
Payables And Accrued Expenses — — — $1.9m $3.2m $4.2m $1.0m
Liabilities, Current — $1.1m $1.4m $2.5m $4.0m $4.9m $1.8m
Total current liabilities $2.6m $1.1m $1.4m $2.5m $4.0m $4.9m $1.8m
Long Term Debt And Capital Lease Obligation — — — $559k $284k $0 $495k
Pensionand Other Post Retirement Benefit Plans Current — — — $400k $472k $475k $426k
Liabilities $2.6m $1.3m $1.4m $3.1m $4.3m $5.0m $2.3m
Stockholders’ equity:
Preferred Stock, Value, Issued — — — — — — $0
Common Stock, Value, Issued — $1k $1k $1k $0 $1k $2k
Retained Earnings (Accumulated Deficit) ($108.9m) ($116.6m) ($130.1m) ($148.3m) ($167.9m) ($190.3m) ($228.2m)
Accumulated Other Comprehensive Income (Loss), Net of Tax — ($2.0m) ($1.5m) ($1.2m) ($830k) ($892k) ($839k)
Additional Paid in Capital, Common Stock — $128.8m $151.6m $152.5m $168.9m $238.4m $326.3m
Preferred stock, $0.0001 par value—5,000,000 shares authorized; no shares issued and outstanding at June 30, 2025 and 2024, respectively — — — — — 0 0
Common stock, $0.0001 par value—160,000,000 shares authorized; 26,250,469 shares and 10,086,119 shares issued and outstanding at June 30, 2025 and 2024, respectively 1k 1k 1k 1k 0 1k 2k
Additional paid-in capital $127.3m $128.8m $151.6m $152.5m $168.9m $238.4m $326.3m
Accumulated other comprehensive loss ($1.9m) ($2.0m) ($1.5m) ($1.2m) ($830k) ($892k) ($839k)
Capital Stock — — — $0 $0 $1k $2k
Gains Losses Not Affecting Retained Earnings — — — ($1.2m) ($830k) ($892k) ($839k)
Stockholders' Equity Attributable to Parent — $10.2m $20.0m $2.9m $202k $47.2m $97.3m
Total Equity Gross Minority Interest — — — $2.9m $202k $47.2m $97.3m
Total Non Current Liabilities Net Minority Interest — — — $559k $284k $38k $495k
Total stockholders' equity $16.6m $10.2m $20.0m $2.9m $202k $47.2m $97.3m
Liabilities and Equity — $11.6m $21.4m $6.0m $4.5m $52.2m $99.6m

Amounts are shown in USD as reported in each fiscal year filing.